Primary mediastinal large B-cell lymphoma is a rare and aggressive form of cancer that primarily affects young adults, particularly women, causing a rapidly growing mass in the chest between the lungs that can lead to serious breathing problems and other complications if left untreated.
Understanding Primary Mediastinal Large B-Cell Lymphoma
Primary mediastinal large B-cell lymphoma, often abbreviated as PMBCL, is a distinct type of cancer that develops from immune system cells called B lymphocytes. These are white blood cells that normally help protect the body from infections. In PMBCL, these cells become abnormal and multiply uncontrollably in a specific area of the chest called the mediastinum, which is the space located between the lungs[2][3].
This disease belongs to a broader category called non-Hodgkin lymphoma, which encompasses many different types of cancers affecting the lymphatic system. PMBCL was initially thought to be just another form of a more common cancer called diffuse large B-cell lymphoma. However, medical researchers discovered that PMBCL has its own unique characteristics, behavior patterns, and response to treatment. Because of these distinctive features, the World Health Organization officially recognized PMBCL as a separate disease entity in 2016[2][8].
What makes PMBCL particularly interesting from a medical standpoint is that it shares certain biological features with classical Hodgkin lymphoma, another type of cancer. The two diseases are thought to originate from similar thymic B cells, which are immune cells that develop in an organ called the thymus located in the chest. This biological similarity helps explain why PMBCL and Hodgkin lymphoma share some common characteristics, including the typical age group they affect and where they develop in the body[10][16].
How Common Is This Disease?
Primary mediastinal large B-cell lymphoma is considered a rare cancer. It accounts for only 2 to 4 percent of all non-Hodgkin lymphoma cases diagnosed each year[2][3][7]. When looking specifically at large B-cell lymphomas, PMBCL represents about 6 to 12 percent of this subgroup[7].
The disease shows a clear pattern in terms of who it affects. Unlike many cancers that primarily strike older individuals, PMBCL predominantly affects young people in their third to fourth decade of life, with the average age at diagnosis being around 35 to 37 years old[8][11]. Adolescents and young adults are particularly vulnerable to this disease.
One of the most distinctive features of PMBCL is that it affects women more often than men. This female predominance is unusual among lymphomas, as many other types of blood cancers tend to affect men more frequently. The female-to-male ratio in PMBCL means that for every two women diagnosed, roughly one man receives this diagnosis[8][16]. This pattern is similar to what doctors observe in nodular sclerosing Hodgkin lymphoma, another cancer that originates from thymic B cells.
What Causes Primary Mediastinal Large B-Cell Lymphoma?
The exact cause of primary mediastinal large B-cell lymphoma remains unknown to medical science. Unlike some cancers that have clear environmental or lifestyle risk factors, researchers have not identified specific triggers that cause this disease to develop. What scientists do know is that PMBCL arises from B lymphocytes that are believed to originate in the thymus gland[5][6].
The thymus is an organ located in the chest, just behind the breastbone. It plays an important role in the immune system, particularly during childhood and adolescence when it helps produce and train immune cells. The B cells that give rise to PMBCL are thought to be thymic B lymphocytes, which explains why the cancer develops specifically in the mediastinum.
At the molecular level, PMBCL involves complex genetic and molecular changes within these B cells. Scientists have discovered that the disease is associated with alterations in certain genes and cellular pathways. Gene expression studies have revealed that PMBCL shares about one-third of its genetic signature with classical Hodgkin lymphoma, highlighting the biological connection between these two diseases[10].
Research has identified several important molecular alterations in PMBCL cells. Copy number alterations of a chromosomal region called 9p24.1 are frequently seen in this disease. These genetic changes lead to increased expression of key genes including programmed death-ligand 1 (PD-L1), PD-L2, and JAK2. These molecular changes help the cancer cells evade the immune system and continue growing[10][16].
Risk Factors
Unlike many other cancers, primary mediastinal large B-cell lymphoma does not have well-established risk factors that people can modify or avoid. The disease appears to develop spontaneously in most cases, without clear connections to lifestyle choices, environmental exposures, or family history.
The most significant demographic factors associated with PMBCL are age and sex. Being a young adult, particularly in the third or fourth decade of life, represents the primary age-related risk pattern. Women face a higher risk than men, though the reasons for this gender difference remain unclear to medical researchers[2][7].
Unlike some other lymphomas, PMBCL does not appear to be strongly associated with immune system deficiencies, viral infections, or chronic inflammatory conditions. The disease typically develops in otherwise healthy individuals without obvious predisposing factors. This makes it challenging for doctors to identify people who might be at higher risk before the disease develops.
Recognizing the Symptoms
The symptoms of primary mediastinal large B-cell lymphoma result primarily from the growing tumor mass in the chest, which puts pressure on surrounding organs and structures. Because the mediastinum is a relatively confined space that houses vital structures including the windpipe, major blood vessels, and the heart, even moderate tumor growth can cause significant symptoms[3][7].
The most common symptoms experienced by people with PMBCL include persistent coughing. This cough often develops gradually and may initially be dismissed as allergies or a respiratory infection. As the tumor grows, the cough typically becomes more frequent and bothersome, potentially interfering with daily activities and sleep[3].
Breathing difficulties are another hallmark symptom. Patients may notice shortness of breath, particularly when lying flat or during physical exertion. Some people experience rapid, shallow breathing even at rest. The tumor mass can compress the windpipe or bronchi, making it physically harder to breathe. This can create a sensation that the lungs feel itchy or uncomfortable from the inside[3][13].
Chest pain or aching is frequently reported. The pain may be localized to the center of the chest, behind the breastbone, or may spread across the chest area. This discomfort results from the tumor pressing against the chest wall or other structures[4].
Difficulty swallowing, medically termed dysphagia, occurs when the tumor mass pushes against the esophagus, the tube that carries food from the mouth to the stomach. People may feel like food is getting stuck or may have trouble swallowing both solid foods and liquids[3].
Many patients develop superior vena cava syndrome, a potentially serious condition that occurs when the tumor compresses the superior vena cava, a large vein that returns blood from the upper body to the heart. This syndrome causes distinctive symptoms including swelling of the face, neck, and upper chest; difficulty breathing; distended veins visible in the chest and neck; and sometimes swelling of the arms. The face may appear puffy or bloated, particularly in the morning[3][7].
Some individuals experience accumulation of fluid around the lungs, a condition called pleural effusion. This fluid buildup further compromises breathing and can cause additional chest discomfort[3].
Blood clots in the veins may develop, particularly in the upper body, due to compression of blood vessels by the tumor. These clots can be painful and potentially dangerous if they travel to other parts of the body.
Unlike many other lymphomas, PMBCL does not typically cause enlarged lymph nodes in the neck, armpits, or groin that people can feel. The lymph node enlargement remains confined to the mediastinum, deep within the chest where it cannot be felt during physical examination[3].
Prevention Strategies
Unfortunately, because the causes of primary mediastinal large B-cell lymphoma remain unknown and there are no identified modifiable risk factors, there are no proven prevention strategies for this disease. Unlike some cancers where lifestyle modifications such as not smoking, maintaining a healthy diet, or avoiding certain environmental exposures can reduce risk, PMBCL appears to develop spontaneously without clear preventable causes.
The absence of known risk factors means that medical science has not yet identified behaviors, exposures, or conditions that people can change to lower their chances of developing PMBCL. There are no screening programs, vaccines, or supplements that have been shown to prevent this particular cancer.
What individuals can do is remain vigilant about their health and seek medical attention promptly if they develop concerning symptoms, particularly persistent respiratory symptoms in young adulthood. Early detection and treatment are crucial for achieving the best possible outcomes, even though the disease itself cannot currently be prevented.
How the Disease Affects the Body
Primary mediastinal large B-cell lymphoma causes changes in normal body function primarily through the physical presence of the tumor mass and its effects on surrounding structures. The disease begins when B lymphocytes in the thymus or nearby lymph nodes undergo malignant transformation, meaning they acquire genetic changes that cause them to grow and divide uncontrollably[2].
As these abnormal cells multiply, they form a tumor mass in the mediastinum. This mass typically grows rapidly, and the majority of patients have what doctors call bulky disease at diagnosis, meaning the tumor is greater than 10 centimeters in diameter[3]. To put this in perspective, 10 centimeters is roughly the size of a grapefruit.
The growing tumor causes problems through several mechanisms. First, it occupies space in the mediastinum, which is a relatively confined area. As the tumor grows, it physically compresses adjacent structures. When it pushes against the trachea or bronchi (the airways), it narrows these passages, making breathing difficult. When it presses against the esophagus, swallowing becomes challenging.
The tumor can also compress major blood vessels, particularly the superior vena cava. This compression impedes blood flow from the upper body back to the heart, causing blood and fluid to back up in the tissues of the face, neck, and upper chest. This explains the characteristic swelling and visible veins seen in superior vena cava syndrome.
At the cellular level, PMBCL cells have developed ways to evade the body’s immune system. The malignant cells often lack or have reduced expression of molecules called MHC class I and II on their surface. These molecules normally help the immune system recognize and attack abnormal cells. By downregulating these markers, PMBCL cells essentially hide from immune surveillance[16].
Additionally, PMBCL cells often overexpress programmed death ligands (PD-L1 and PD-L2) on their surface. These molecules send inhibitory signals to immune cells, essentially telling the body’s T lymphocytes not to attack. This represents another immune evasion strategy that allows the cancer cells to grow unchecked[10][16].
The malignant B cells in PMBCL typically express specific markers on their surface that doctors can detect through laboratory testing. These include CD19, CD20, CD22, and CD79a, which are characteristic B-cell markers. However, unlike normal B cells, the cancerous cells in PMBCL often lack surface immunoglobulin, the antibody proteins that normal B cells produce[7][16].
Many PMBCL cells show weak expression of CD30, a protein also found in Hodgkin lymphoma. This is one of the features that highlights the biological similarity between these two diseases. The tumor cells typically have fibrosis and sclerosis, meaning there is fibrous scar-like tissue interspersed with the cancer cells[7].
Within the cancer cells, several molecular pathways become constitutively activated, meaning they are constantly turned on when they should be regulated. The JAK-STAT pathway and the NF-κB pathway are two important signaling systems that promote cell growth and survival. In PMBCL, these pathways remain persistently active, driving the continued multiplication of cancer cells[16].
Fortunately, PMBCL tends to remain localized to the mediastinum in most cases at the time of diagnosis. The majority of patients are diagnosed with early-stage disease, meaning the cancer has not yet spread extensively to other parts of the body[3]. However, the tumor can invade locally into nearby organs such as the lungs, chest wall, pleura (the lining around the lungs), or pericardium (the sac around the heart)[16].
